Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:

“Have you ever met advanced cancer patients who had disease failure on many lines of treatment?

Do you remember your feelings when he asked you for more chance of treatment, while you have nothing to give him?

This feeling is very unpleasant: feelings of helplessness, and that nothing can be done for patients who are optimistic.

Re-irradiation is one of the challenges and optimistic lines of treatment that give a chance for these patients, who had previously full doses of radical radiotherapy.

Thanks for the European Society for Radiotherapy and Oncology (ESTRO) organizing group for this very fruitful workshop, and webinars, who explained the whole issues and challenges of re-irradiation.

One of the main advantages of this webinar is being very open for discussion with experts from all over the world.
thanks for your efforts Ali Zaila, Anand Jadhav and Stephanie Tanadini-Lang and all organising group of ESTRO workshop.”

View additional information.
Source: Rasha Aboelhassan/LinkedIn

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”